Analysts’ Viewpoint on Market Scenario
R&D of advanced transdermal patches and increase in advantages of transdermal medicines over oral and ingested medications are fueling the transdermal skin patches market value. The convenience, non-invasiveness, and ability to maintain steady drug concentrations in plasma make transdermal an attractive patch-based drug delivery method. Moreover, surge in prevalence of pain-related disorders and the global burden of tobacco use are contributing to the growth of the global market.
Manufacturers are focusing on collaborations, acquisitions, and innovative product launches. They are engaged in developing smart, dissolving/biodegradable, high-loading/release, 3D-printed, and wearable patches to increase their market share. Furthermore, advancements in drug delivery through skin patches are likely to create immense opportunities for market players.
Transdermal skin patches are designed to transport active drug ingredients through the skin into the systemic bloodstream via diffusion. Transdermal drug delivery offers ease of use to patients and bestows a plethora of advantages, including bypassing first-pass metabolism and evading the perils of enzymatic or gastric drug degradation. Furthermore, this route facilitates the attainment of steady-state plasma concentrations of the administered drug, thereby heralding a new era in therapeutic interventions.
Commercialization of transdermal patches has transformed them into convenient, durable, and hassle-free products that can be comfortably worn for extended periods, often up to seven days. These patches are used for the treatment of osteoporosis in men, migraines, Alzheimer's disease, and hormonal imbalances.
Transdermal skin patches offer relief from gastrointestinal toxicity and acidity by circumventing initial metabolism, as well as from the degradation potential posed by enzymes and gastric conditions. This route of drug delivery sidesteps the conventional use of oral ingestion or syringe-based injections, offering a non-invasive alternative that ameliorates the challenges often associated with intravenous or parenteral therapies.
The ability of transdermal patches to provide convenient, painless self-administration of drugs and maintain consistent plasma drug concentrations is further boosting their demand, thereby fueling the transdermal skin patches market progress.
Key manufacturers and industry players have demonstrated a heightened commitment to innovation and development through funding, aiming to introduce novel drugs and pioneering transdermal therapy solutions. In May 2023, BioNxt Solutions Inc. secured government approval to conduct a comparative drug absorption study for its transdermal Rotigotine patch, designed for Parkinson's disease treatment.
Similarly, in April 2023, Revive Therapeutics Ltd. embarked on the research and development of a transdermal microneedle patch for delivering 3,4-Methylenedioxy methamphetamine (MDMA), enhancing the potential therapeutic utility of this substance for mental health and abuse disorders. Such strategic initiatives are likely to boost transdermal skin patches market revenue during the forecast period.
In a landscape where the merits of various drug delivery routes are precisely weighed, transdermal medication emerges as a compelling candidate, as compared to oral and ingested medications. The potential adverse gastrointestinal effects associated with oral medications, such as nausea or upset stomach, can be sidestepped through the use of transdermal patches.
Transdermal patches ensure a consistent drug dosage over an extended timeframe by bypassing the digestive system and first-pass metabolism. This versatile approach finds applications in delivering drugs for diverse indications, ranging from chronic pain to motion sickness and hormone replacement therapy.
The global proliferation of tobacco consumption, particularly in the form of cigarettes, has given rise to significant healthcare burdens. The World Health Organization (WHO) data from May 2022 indicates that 22.3% of the global population engaged in tobacco use in 2021, of which 36.7% were men and 7.8% were women. Rise in number of smokers across the globe is augmenting demand for nicotine transdermal skin patches. This, in turn, is anticipated to drive the global transdermal skin patches market development during the forecast period.
The prescription sales type segment is likely to account for major share of the global market in the next few years due to the rise in prevalence of chronic diseases and growth in demand for convenient and effective drug delivery systems.
Prescription-based transdermal skin patches are designed to deliver specific medications directly through the skin. These patches are gaining substantial popularity among healthcare professionals and patients alike.
Prescription transdermal patches provide controlled and sustained release of medications. They also offer several advantages, including improved patient compliance and reduced side effects. As a result, they have become a preferred choice for delivering various therapeutic agents, such as analgesics, hormone replacement therapies, and cardiovascular drugs, thereby driving their transdermal skin patches market dominance.
In terms of product type, the global market has been classified into reservoir, drug-in-adhesive, microneedle, matrix, and others (vapor, etc.). The microneedle product type segment is projected to witness the fastest growth in the global market during the forecast period.
Ongoing extensive research and advancements in the field of microneedle technology to facilitate the efficient delivery of therapeutics are propelling the growth of this segment. The effectiveness of microneedles has been demonstrated in numerous clinical trials, but there is still a significant amount of preclinical research being conducted across the globe.
Experts from academia and regulatory organizations are collaborating to ensure the safe and effective clinical utilization of microneedles. Microneedle-based technology is expected to contribute to improved prevention, diagnosis, and control of illnesses in the near future. This would ultimately enhance the overall health-related quality of life for patients worldwide.
In terms of application, the global market has been segmented into pain management, hormonal disorders, smoking reduction and cessation aid, neurological disorders, cardiovascular disorders, and others (motion sickness, overactive bladder, etc.). The pain management application segment is anticipated to account for major share of the global market during the forecast period. Surge in prevalence of pain-related disorders and encompassing conditions including migraines, rheumatoid arthritis, diabetic neuropathy, and osteoarthritis, are contributing to the growth of this segment.
Back pain is often accompanied by high recurrence rates and substantial lifetime prevalence figures, underscoring the significance of pain relief interventions. Rise in prevalence of migraine, categorized as a highly prevalent neurological ailment, is also fueling demand for effective patches for pain relief.
Based on distribution channel, the global market has been segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies distribution channel segment is projected to account for dominant share of the global market from 2023 to 2031.
Hospital pharmacies play a crucial role in ensuring the availability and distribution of transdermal patches to healthcare facilities and patients within a hospital setting. These pharmacies have well-established networks, efficient supply chains, and regulatory compliance, making them the primary source of transdermal patches for inpatient and outpatient care.
Moreover, hospital pharmacies often maintain close relationships with pharmaceutical manufacturers and suppliers, facilitating the timely procurement of transdermal patches and ensuring the availability of a wide range of products.
North America held major share of the global sector in 2022. As per the latest transdermal skin patches market research analysis, the region is anticipated to lead the global industry during the forecast period.
Presence of leading players and a highly structured healthcare industry are some of the factors contributing to the transdermal skin patches market dynamics of North America. Moreover, rise in government initiatives and burgeoning research partnerships are also contributing to the transdermal skin patches market growth in the region.
The transdermal skin patches market size is likely to increase in North America owing to the implementation of robust healthcare policies, increase in prevalence of chronic conditions, and presence of a mature healthcare market, especially in the U.S. Furthermore, the escalating number of smokers in North America is fueling the demand for nicotine transdermal patches. This, in turn, is positively impacting market statistics in the region.
The global landscape is fragmented, with the presence of a few prominent manufacturers that control majority of the transdermal skin patches market share. According to the latest transdermal skin patches market forecast, key players are implementing innovative strategies such as mergers, collaborations, new product launches, and acquisitions.
Some of the leading players operating in the market are Hisamitsu Pharmaceutical Co., Inc., Viatris Inc., Nitto Denko Corporation, Novartis AG, Luye Pharma Group, Samyang Holdings Corporation, Teikoku Pharma, AdhexPharma, Sparsha Pharma International Pvt. Ltd., and Gedeon Richter Plc. These players are following the latest transdermal skin patches market trends to avail lucrative revenue opportunities.
Key players have been profiled in the transdermal skin patches market report based on parameters such as company overview, financial overview, strategies, portfolio, segments, and recent developments.
| Attribute | Detail |
|---|---|
| Market Value in 2022 | US$ 7.7 Bn |
| Market Forecast Value in 2031 | More than US$ 11.5 Bn |
| Growth Rate (CAGR) | 4.6% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 7.7 Bn in 2022
It is projected to exceed US$ 11.5 Bn by 2031
The CAGR is anticipated to be 4.6% from 2023 to 2031
R&D of advanced transdermal patches and advantages of transdermal medicines over oral and ingested medications
The pain management application segment held major share in 2022
North America is estimated to account for major share during the forecast period
Hisamitsu Pharmaceutical Co., Inc., Viatris Inc., Nitto Denko Corporation, Novartis AG, Luye Pharma Group, Samyang Holdings Corporation, Teikoku Pharma, AdhexPharma, Sparsha Pharma International Pvt. Ltd., and Gedeon Richter Plc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Transdermal Skin Patches Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Transdermal Skin Patches Market Analysis and Forecast, 2017 - 2031
4.4.1. Market Revenue Projection (US$ Bn)
5. Key Insights
5.1. Regulatory Scenario by Region/Globally
5.2. Disease Prevalence & Incidence Rate Globally with Key Countries
5.3. Pipeline Analysis
5.4. Key Product/brand Analysis
5.5. COVID-19 Impact on the Industry
6. Global Transdermal Skin Patches Market Analysis and Forecast, By Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product Type, 2017 - 2031
6.3.1. Reservoir
6.3.2. Drug-in-Adhesive
6.3.2.1. Single Layer
6.3.2.2. Multilayer
6.3.3. Microneedle
6.3.4. Matrix
6.3.5. Others (Vapor, etc.)
6.4. Market Attractiveness By Product Type
7. Global Transdermal Skin Patches Market Analysis and Forecast, By Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Application, 2017 - 2031
7.3.1. Pain Management
7.3.2. Hormonal Disorders
7.3.3. Smoking Reduction and Cessation Aid
7.3.4. Neurological Disorders
7.3.5. Cardiovascular Disorders
7.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
7.4. Market Attractiveness By Application
8. Global Transdermal Skin Patches Market Analysis and Forecast, By Sales Type
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Sales Type, 2017 - 2031
8.3.1. Prescription
8.3.2. Over-the-Counter (OTC)
8.4. Market Attractiveness By Sales Type
9. Global Transdermal Skin Patches Market Analysis and Forecast, By Distribution Channel
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By Distribution Channel, 2017 - 2031
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Online Pharmacies
9.4. Market Attractiveness By Distribution Channel
10. Global Transdermal Skin Patches Market Analysis and Forecast, By Region
10.1. Key Findings
10.2. Market Value Forecast By Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America Transdermal Skin Patches Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Product Type, 2017 - 2031
11.2.1. Reservoir
11.2.2. Drug-in-Adhesive
11.2.2.1. Single Layer
11.2.2.2. Multilayer
11.2.3. Microneedle
11.2.4. Matrix
11.2.5. Others (Vapor, etc.)
11.3. Market Value Forecast By Application, 2017 - 2031
11.3.1. Pain Management
11.3.2. Hormonal Disorders
11.3.3. Smoking Reduction and Cessation Aid
11.3.4. Neurological Disorders
11.3.5. Cardiovascular Disorders
11.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
11.4. Market Value Forecast By Sales Type, 2017 - 2031
11.4.1. Prescription
11.4.2. Over-the-Counter (OTC)
11.5. Market Value Forecast By Distribution Channel, 2017 - 2031
11.5.1. Hospital Pharmacies
11.5.2. Retail Pharmacies
11.5.3. Online Pharmacies
11.6. Market Value Forecast By Country, 2017 - 2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Application
11.7.3. By Sales Type
11.7.4. By Distribution Channel
11.7.5. By Country
12. Europe Transdermal Skin Patches Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product Type, 2017 - 2031
12.2.1. Reservoir
12.2.2. Drug-in-Adhesive
12.2.2.1. Single Layer
12.2.2.2. Multilayer
12.2.3. Microneedle
12.2.4. Matrix
12.2.5. Others (Vapor, etc.)
12.3. Market Value Forecast By Application, 2017 - 2031
12.3.1. Pain Management
12.3.2. Hormonal Disorders
12.3.3. Smoking Reduction and Cessation Aid
12.3.4. Neurological Disorders
12.3.5. Cardiovascular Disorders
12.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
12.4. Market Value Forecast By Sales Type, 2017 - 2031
12.4.1. Prescription
12.4.2. Over-the-Counter (OTC)
12.5. Market Value Forecast By Distribution Channel, 2017 - 2031
12.5.1. Hospital Pharmacies
12.5.2. Retail Pharmacies
12.5.3. Online Pharmacies
12.6. Market Value Forecast By Country, 2017 - 2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Application
12.7.3. By Sales Type
12.7.4. By Distribution Channel
12.7.5. By Country
13. Asia Pacific Transdermal Skin Patches Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product Type, 2017 - 2031
13.2.1. Reservoir
13.2.2. Drug-in-Adhesive
13.2.2.1. Single Layer
13.2.2.2. Multilayer
13.2.3. Microneedle
13.2.4. Matrix
13.2.5. Others (Vapor, etc.)
13.3. Market Value Forecast By Application, 2017 - 2031
13.3.1. Pain Management
13.3.2. Hormonal Disorders
13.3.3. Smoking Reduction and Cessation Aid
13.3.4. Neurological Disorders
13.3.5. Cardiovascular Disorders
13.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
13.4. Market Value Forecast By Sales Type, 2017 - 2031
13.4.1. Prescription
13.4.2. Over-the-Counter (OTC)
13.5. Market Value Forecast By Distribution Channel, 2017 - 2031
13.5.1. Hospital Pharmacies
13.5.2. Retail Pharmacies
13.5.3. Online Pharmacies
13.6. Market Value Forecast By Country, 2017 - 2031
13.6.1. Japan
13.6.2. China
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Application
13.7.3. By Sales Type
13.7.4. By Distribution Channel
13.7.5. By Country
14. Latin America Transdermal Skin Patches Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Product Type, 2017 - 2031
14.2.1. Reservoir
14.2.2. Drug-in-Adhesive
14.2.2.1. Single Layer
14.2.2.2. Multilayer
14.2.3. Microneedle
14.2.4. Matrix
14.2.5. Others (Vapor, etc.)
14.3. Market Value Forecast By Application, 2017 - 2031
14.3.1. Pain Management
14.3.2. Hormonal Disorders
14.3.3. Smoking Reduction and Cessation Aid
14.3.4. Neurological Disorders
14.3.5. Cardiovascular Disorders
14.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
14.4. Market Value Forecast By Sales Type, 2017 - 2031
14.4.1. Prescription
14.4.2. Over-the-Counter (OTC)
14.5. Market Value Forecast By Distribution Channel, 2017 - 2031
14.5.1. Hospital Pharmacies
14.5.2. Retail Pharmacies
14.5.3. Online Pharmacies
14.6. Market Value Forecast By Country, 2017 - 2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Application
14.7.3. By Sales Type
14.7.4. By Distribution Channel
14.7.5. By Country
15. Middle East & Africa Transdermal Skin Patches Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast By Product Type, 2017 - 2031
15.2.1. Reservoir
15.2.2. Drug-in-Adhesive
15.2.2.1. Single Layer
15.2.2.2. Multilayer
15.2.3. Microneedle
15.2.4. Matrix
15.2.5. Others (Vapor, etc.)
15.3. Market Value Forecast By Application, 2017 - 2031
15.3.1. Pain Management
15.3.2. Hormonal Disorders
15.3.3. Smoking Reduction and Cessation Aid
15.3.4. Neurological Disorders
15.3.5. Cardiovascular Disorders
15.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
15.4. Market Value Forecast By Sales Type, 2017 - 2031
15.4.1. Prescription
15.4.2. Over-the-Counter (OTC)
15.5. Market Value Forecast By Distribution Channel, 2017 - 2031
15.5.1. Hospital Pharmacies
15.5.2. Retail Pharmacies
15.5.3. Online Pharmacies
15.6. Market Value Forecast By Country, 2017 - 2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of the Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product Type
15.7.2. By Application
15.7.3. By Sales Type
15.7.4. By Distribution Channel
15.7.5. By Country
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of companies)
16.2. Market Share Analysis By Company (2022)
16.3. Company Profiles
16.3.1. Hisamitsu Pharmaceutical Co., Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Viatris Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Nitto Denko Corporation
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Novartis AG
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Luye Pharma Group
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Teikoku Pharma
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Samyang Holdings Corporation
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Gedeon Richter PLC
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. AdhexPharma
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Sparsha Pharma International Pvt. Ltd.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
List of Tables
Table 1. Global Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
Table 2. Global Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
Table 3. Global Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
Table 4. Global Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
Table 5. Global Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031
Table 6. North America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
Table 7. North America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
Table 8. North America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
Table 9. North America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
Table 10. North America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031
Table 11. Europe Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
Table 12. Europe Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
Table 13. Europe Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
Table 14. Europe Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
Table 15. Europe Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031
Table 16. Asia Pacific Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
Table 17. Asia Pacific Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
Table 18. Asia Pacific Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
Table 19. Asia Pacific Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
Table 20. Asia Pacific Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031
Table 21. Latin America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
Table 22. Latin America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
Table 23. Latin America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
Table 24. Latin America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
Table 25. Latin America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031
Table 26. Middle East & Africa Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
Table 27. Middle East & Africa Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
Table 28. Middle East & Africa Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
Table 29. Middle East & Africa Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
Table 30. Middle East & Africa Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031
List of Figures
Figure 1. Global Transdermal Skin Patches Market Value (US$ Bn) Forecast, 2017-2031
Figure 2. Global Transdermal Skin Patches Market Value Share by Product Type, 2017-2031
Figure 3. Global Transdermal Skin Patches Market Value Share by Application, 2017-2031
Figure 4. Global Transdermal Skin Patches Market Value Share by Sales Type, 2017-2031
Figure 5. Global Transdermal Skin Patches Market Value Share by Distribution Channel, 2017-2031
Figure 6. Global Transdermal Skin Patches Market Value Share Analysis by Product Type, 2022 and 2031
Figure 7. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Reservoir, 2017-2031
Figure 8. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Drug-in-Adhesive, 2017-2031
Figure 9. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Microneedle, 2017-2031
Figure 10. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Matrix, 2017-2031
Figure 11. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Others, 2017-2031
Figure 12. Global Transdermal Skin Patches Market Attractiveness Analysis by Product Type, 2023-2031
Figure 13. Global Transdermal Skin Patches Market Value Share Analysis by Application, 2022 and 2031
Figure 14. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Pain Management, 2017-2031
Figure 15. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Hormonal Disorders, 2017-2031
Figure 16. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Smoking Reduction and Cessation Aid, 2017-2031
Figure 17. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Neurological Disorders, 2017-2031
Figure 18. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Cardiovascular Disorders, 2017-2031
Figure 19. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Others, 2017-2031
Figure 20. Global Transdermal Skin Patches Market Attractiveness Analysis by Application, 2023-2031
Figure 21. Global Transdermal Skin Patches Market Value Share Analysis by Sales Type, 2022 and 2031
Figure 22. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Prescription, 2017-2031
Figure 23. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Over-the-Counter (OTC), 2017-2031
Figure 24. Global Transdermal Skin Patches Market Attractiveness Analysis by Sales Type, 2023-2031
Figure 25. Global Transdermal Skin Patches Market Value Share Analysis by Distribution Channel, 2022 and 2031
Figure 26. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Hospital Pharmacies, 2017-2031
Figure 27. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Retail Pharmacies, 2017-2031
Figure 28. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Online Pharmacies, 2017-2031
Figure 29. Global Transdermal Skin Patches Market Attractiveness Analysis by Distribution Channel, 2023-2031
Figure 30. Global Transdermal Skin Patches Market Value Share Analysis by Region, 2022 and 2031
Figure 31. Global Transdermal Skin Patches Market Attractiveness Analysis by Region, 2023-2031
Figure 32. North America Transdermal Skin Patches Market Value (US$ Bn) Forecast, 2017-2031
Figure 33. North America Transdermal Skin Patches Market Value Share Analysis by Country, 2022 and 2031
Figure 34. North America Transdermal Skin Patches Market Attractiveness Analysis by Country, 2023-2031
Figure 35. North America Transdermal Skin Patches Market Value Share Analysis by Product Type, 2022 and 2031
Figure 36. North America Transdermal Skin Patches Market Attractiveness Analysis by Product Type, 2023-2031
Figure 37. North America Transdermal Skin Patches Market Value Share Analysis by Application, 2022 and 2031
Figure 38. North America Transdermal Skin Patches Market Attractiveness Analysis by Application, 2023-2031
Figure 39. North America Transdermal Skin Patches Market Value Share Analysis by Sales Type, 2022 and 2031
Figure 40. North America Transdermal Skin Patches Market Attractiveness Analysis by Sales Type, 2023-2031
Figure 41. North America Transdermal Skin Patches Market Value Share Analysis by Distribution Channel, 2022 and 2031
Figure 42. North America Transdermal Skin Patches Market Attractiveness Analysis by Distribution Channel, 2023-2031
Figure 43. Europe Transdermal Skin Patches Market Value (US$ Bn) Forecast, 2017-2031
Figure 44. Europe Transdermal Skin Patches Market Value Share Analysis by Country, 2022 and 2031
Figure 45. Europe Transdermal Skin Patches Market Attractiveness Analysis by Country, 2023-2031
Figure 46. Europe Transdermal Skin Patches Market Value Share Analysis by Product Type, 2022 and 2031
Figure 47. Europe Transdermal Skin Patches Market Attractiveness Analysis by Product Type, 2023-2031
Figure 48. Europe Transdermal Skin Patches Market Value Share Analysis by Application, 2022 and 2031
Figure 49. Europe Transdermal Skin Patches Market Attractiveness Analysis by Application, 2023-2031
Figure 50. Europe Transdermal Skin Patches Market Value Share Analysis by Sales Type, 2022 and 2031
Figure 51. Europe Transdermal Skin Patches Market Attractiveness Analysis by Sales Type, 2023-2031
Figure 52. Europe Transdermal Skin Patches Market Value Share Analysis by Distribution Channel, 2022 and 2031
Figure 53. Europe Transdermal Skin Patches Market Attractiveness Analysis by Distribution Channel, 2023-2031
Figure 54. Asia Pacific Transdermal Skin Patches Market Value (US$ Bn) Forecast, 2017-2031
Figure 55. Asia Pacific Transdermal Skin Patches Market Value Share Analysis by Country, 2022 and 2031
Figure 56. Asia Pacific Transdermal Skin Patches Market Attractiveness Analysis by Country, 2023-2031
Figure 57. Asia Pacific Transdermal Skin Patches Market Value Share Analysis by Product Type, 2022 and 2031
Figure 58. Asia Pacific Transdermal Skin Patches Market Attractiveness Analysis by Product Type, 2023-2031
Figure 59. Asia Pacific Transdermal Skin Patches Market Value Share Analysis by Application, 2022 and 2031
Figure 60. Asia Pacific Transdermal Skin Patches Market Attractiveness Analysis by Application, 2023-2031
Figure 61. Asia Pacific Transdermal Skin Patches Market Value Share Analysis by Sales Type, 2022 and 2031
Figure 62. Asia Pacific Transdermal Skin Patches Market Attractiveness Analysis by Sales Type, 2023-2031
Figure 63. Asia Pacific Transdermal Skin Patches Market Value Share Analysis by Distribution Channel, 2022-2031
Figure 64. Asia Pacific Transdermal Skin Patches Market Attractiveness Analysis by Distribution Channel, 2023-2031
Figure 65. Latin America Transdermal Skin Patches Market Value (US$ Bn) Forecast, 2017-2031
Figure 66. Latin America Transdermal Skin Patches Market Value Share Analysis by Country, 2022 and 2031
Figure 67. Latin America Transdermal Skin Patches Market Attractiveness Analysis by Country, 2023-2031
Figure 68. Latin America Transdermal Skin Patches Market Value Share Analysis by Product Type, 2022 and 2031
Figure 69. Latin America Transdermal Skin Patches Market Attractiveness Analysis by Product Type, 2023-2031
Figure 70. Latin America Transdermal Skin Patches Market Value Share Analysis by Application, 2022 and 2031
Figure 71. Latin America Transdermal Skin Patches Market Attractiveness Analysis by Application, 2023-2031
Figure 72. Latin America Transdermal Skin Patches Market Value Share Analysis by Sales Type, 2022 and 2031
Figure 73. Latin America Transdermal Skin Patches Market Attractiveness Analysis by Sales Type, 2022-2031
Figure 74. Latin America Transdermal Skin Patches Market Value Share Analysis by Distribution Channel, 2022-2031
Figure 75. Latin America Transdermal Skin Patches Market Attractiveness Analysis by Distribution Channel, 2023-2031
Figure 76. Middle East & Africa Transdermal Skin Patches Market Value (US$ Bn), 2017-2031
Figure 77. Middle East & Africa Transdermal Skin Patches Market Value Share Analysis by Country, 2022 and 2031
Figure 78. Middle East & Africa Transdermal Skin Patches Market Attractiveness by Country, 2023-2031
Figure 79. Middle East & Africa Transdermal Skin Patches Market Value Share Analysis by Product Type, 2022 and 2031
Figure 80. Middle East & Africa Transdermal Skin Patches Market Attractiveness by Product Type, 2023-2031
Figure 81. Middle East & Africa Transdermal Skin Patches Market Value Share Analysis by Application, 2022 and 2031
Figure 82. Middle East & Africa Transdermal Skin Patches Market Attractiveness by Application, 2023-2031
Figure 83. Middle East & Africa Transdermal Skin Patches Market Value Share Analysis by Sales Type, 2022 and 2031
Figure 84. Middle East & Africa Transdermal Skin Patches Market Attractiveness by Sales Type, 2023-2031
Figure 85. Middle East & Africa Transdermal Skin Patches Market Value Share by Distribution Channel, 2022 and 2031
Figure 86. Middle East & Africa Transdermal Skin Patches Market Attractiveness by Distribution Channel, 2023-2031
Figure 87. Company Share Analysis Transdermal Skin Patches, 2022
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Transdermal Skin Patches Market
*86 figures and 60 tables includes